Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

In acute coronavirus disease 19 (COVID‐19) patients, effective clinical risk stratification has
important implications on treatment and therapeutic resource distribution. This article …

Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan,
China and has since spread rapidly all over the world causing a global pandemic. While the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized
by highly heterogeneous manifestations ranging from asymptomatic cases to death for still …

Aims The prevalence and prognostic implications of coronary artery disease (CAD) in
patients infected by the novel coronavirus 2019 (COVID-19) disease remain unclear …

Introduction: Influenza and the coronavirus disease 2019 (COVID-19) are two potentially
severe viral infections causing significant morbidity and mortality. The causative viruses …

Background The effects of coronavirus disease 2019 (COVID-19) on the cardiovascular
system are well established. However, knowledge gaps in the clinical implications of cardiac …

Background Echocardiography has become an integral part of the management of critically
ill patients. It helps to diagnose and treat various conditions. COVID-19 patients can develop …

Coronavirus disease 19 (COVID-19) is responsible for one of the worst pandemics in human
history. The causative virus, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS …

Background: Data regarding the combined prognostic role of biomarkers and risk scores in
relation with the history of atherosclerotic cardiovascular disease (ASCVD) in COVID-19 …